The Spark

“The emancipation of the working class will only be achieved by the working class itself.” — Karl Marx

Pharma USA:
Pay Up or Drop Dead

Oct 28, 2013

Asthma, the most common chronic disease in the U.S. affecting 40 million people, kills 3300 people every year. Yet the medicine to prevent asthma attacks is readily available.

Since the drugs exist, why do so many have trouble breathing and even die from asthma?

It’s always about the “Benjamins” – the money that can be made for the pharmaceutical companies! Millions of asthma patients can’t afford inhalers or hold the inhalers without using them due to the cost.

Even with insurance, co-pays for Advair, one of the most common asthma inhalers, range from $30 to $50 per inhaler. Maxair, another inhaler, comes with a price tag of $600 at Costco! Even with insurance, the co-pays can cost $125 or more. And Big Pharma charges Medicare and Medicaid programs an exorbitant price, over $200, for an inhaler that would cost $7.00 in a French pharmacy.

Thanks to those blood-sucking toadies known as Congress, the laws are written so that these pretend “health-care” companies can collect as much as they want to charge.

It’s a simple calculation in a for-profit system: Pay more or stop breathing.